Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SRE vs GSK✓SelectedUSD · GSKSRE vs GSK performance historyLatest closeAs of+0.71%11/13
Stock and ETF performance explorer

SRE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,434.4%
GSK return
+185.5%
Excess return
+1,248.9%
Maximum drawdown
-45.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%+0.5%+0.2%+0.6%
7D+1.8%+1.1%+0.6%+1.4%
30D-3.0%+6.3%-9.3%-4.9%
3M-7.3%+1.8%-9.1%-8.1%
6M-11.9%+1.7%-13.5%-12.8%
YTD-7.9%+6.5%-14.4%-10.7%
1Y-11.1%+9.5%-20.6%-14.6%
3Y+24.8%+65.3%-40.5%+2.7%
5Y+52.4%+43.7%+8.6%+29.5%
10Y+127.9%+104.1%+23.8%+72.4%
All+1,434.4%+185.5%+1,248.9%+873.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling